AMERICAN CALCIGLU (Equivalent of 10% Calcium Gluconate) INJECTION 2 x 5x 10ml
Generic Name: Calcium Gluconate
Brand Name: American Calciglu
Class: Mineral supplement, Calcium therapy
Pack Size: 2 Packs (each containing 5 ampoules of 10ml solution)
Strength: 10% Calcium Gluconate (100 mg/ml)
Amount: ₦6,200.

Description: AMERICAN CALCIGLU is a sterile, non-pyrogenic solution containing Calcium Gluconate, a calcium salt used primarily for treating conditions associated with low calcium levels in the blood. The solution is equivalent to 10% Calcium Gluconate, providing essential calcium ions crucial for various physiological functions, including muscle contraction, bone formation, and nerve conduction. Each package contains 2 sets of 5 ampoules, each with a 10ml solution.

Key Features:
• High Purity: Contains 10% Calcium Gluconate, offering a reliable source of calcium ions.
• Versatile Use: Suitable for treating hypocalcemia, tetany, and other conditions requiring rapid calcium replenishment.
• Convenient Packaging: Comes in ampoules, ensuring sterility and accurate dosing.
• Rapid Action: Provides immediate calcium supplementation in acute situations.

Side Effects:
Common side effects may include:
• Injection site reactions (pain, redness, swelling)
• Feeling of heat waves
• Tingling sensations
Less common but serious side effects:
• Hypotension (especially with rapid infusion)
• Cardiac arrhythmias
• Hypercalcemia (symptoms may include nausea, vomiting, constipation, and confusion)

Caution:
• Intravenous Use Only: Ensure proper dilution and slow administration to avoid complications.
• Monitoring: Regular monitoring of calcium levels is necessary to avoid hypercalcemia.
• Contraindications: Not to be used in patients with hypercalcemia, ventricular fibrillation, or severe renal insufficiency.
• Drug Interactions: May interact with other medications, such as cardiac glycosides (e.g., digoxin) or calcium channel blockers.
• Special Populations: Use caution in patients with a history of renal impairment, cardiac disease, or in those receiving digitalis.